Case Study Interview Matrix

Attachment 5d: Case Study Interview Matrix

Evaluation Question	DP13-1314	DP13-1315	Probes	Baseline			Follow Up
				PD/PM1	Evaluator	Partner	PD/PM
Evaluation Question 1: How are DP13-1314 and DP13-1315 grantees implementing the components of their respective FOAs to build capacity among their target audiences?
EQ 1A. How are DP13- 1314 grantees implementing the components of their FOA to build capacity among their target audience?	Briefly describe your organization and how long it has been involved with [insert DP13-1314 grantee organization name]?				X	X
	How would you describe your role within your organization?	__2	How long have you worked at [insert name of organization]? How did you originally get involved?	X	X	X
	Describe your organization’s national comprehensive cancer control (NCCCP) network.		How does your network operate? Describe your network’s governing structure (e.g., decision making, communication). How is your network structured? For example, is your network centralized (e.g., core group of network members who provide TTA) or decentralized (e.g., no formal group of members)? Describe the number and types of organizations that comprise your network. Describe key activities of your network (e.g., engagement opportunities, trainings). Has the national network changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
	Describe your organization’s goals and objectives for the NCCCP network.		How would you describe the vision of the network and how does this align with what your organization wants to achieve? Have your organization’s goals and/or objectives, or your national network, changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
	Describe you and/or your organization’s role in the national comprehensive cancer control network.		How do you/ your organization’s help the network operate? How would describe your/ your organization’s experience with participating in the network?		X	X	X
	You mentioned that your key network activities include ___ [LIST]. In what ways has your organization promoted evidence-based interventions for tobacco control and cancer prevention?		What trainings has your organization offered to promote evidence-based interventions among network participants? What technical assistance resources/materials does your organization offer to promote evidence-based interventions among network participants? What efforts has your organization made to educate CDC about your network, its participants, and/or your target audience?	X			X
	In what ways has your organization worked to develop and maintain other partnerships related to your national network (e.g., other partner organizations that help to support FOA components)?		In what ways has your organization engaged other partners over time (e.g., regular communication, meetings, MOUs, etc.)? How has your organization convened other partners to promote health system interventions (e.g., meetings, conference calls, etc.)? What strategies or methods has your organization used to promote health system interventions among other partners? Please provide any examples.	X			X
	In what ways has your organization worked to promote community-clinical linkages network participants?		What types of community resources, if any, has your organization promoted? What types of community-clinical linkages, if any, has your organization promoted? How often has your network promoted community resources? What strategies or activities has your organization used to promote community resources?	X			X
	In what ways has your organization translated and/or disseminated target audience data to network participants?		Describe any data your organization has translated and/or disseminated. Please provide any specific examples. How often has your organization disseminated data about the target audience? What strategies or methods does your organization use to disseminate data?	X			X
	Describe your organization's partnership with [DP13-1314 grantee organization name] with respect to implementation of TTA for NCCCP and NSTCP grantees.		How does your organization interact with [insert DP13-1314 grantee organization name]? How does your organization communicate with [insert DP13-1314 grantee organization name]? How long has your organization worked [insert DP13-1314 grantee organization name]? What components of TTTA does your organization support?			X
EQ 1B. What factors affect grantees’ implementation of DP13-1314 FOA components?	What factors have affected your organization’s ability to implement the DP13-1314 FOA components? Please note and describe any factors that have changed since the beginning of the FOA. [follow-up only]		Are there any contextual factors that have affected your organization’s ability to implement FOA components? If so, which factors and components? Costs/funding Staffing/personnel Amount of time Program maturity/infrastructure Staff capacity Access to those with subject matter expertise Partnerships Are there any factors within your organization that have affected your ability to implement FOA components? If so, which factors and components? History Maturity Mission Leadership Are there any aspects of the cooperative agreement that have affected your organization’s ability to implement FOA components? If so, which factors and components? CDC TA received Tools/resources made available by CDC Have other organizations that comprise the network affected your organization’s ability to implement the FOA? If so, which partnerships and in what ways?	X			X
	What resources, if any, has your organization provided to [insert Organization name] to support the implementation of their NCCCP network?		Has your organization provided additional funding? If so, please describe. Has your organization provided nonmonetary resources (such as volunteers, time, expertise,)? If so, please describe.		X	X
EQ 1C. How are DP13-1315 grantees implementing the components of their FOA to build capacity among their target audience?		Briefly describe your organization and how long it has been involved with [insert DP13-1315 grantee organization name]?			X	X
		How would you describe your role within your organization?	How long have you worked at [insert name of organization]? How did you originally get involved?	X	X	X
		Describe your organization’s overall coordination of TTA activities.	What is your organization’s role in coordinating TTA activities under the FOA? What strategies has your organization used to coordinate TTA activities? Has your organization’s coordination of TTA activities changed since the beginning the FOA? If so, please describe. [follow-up only]	X			X
		Describe your organization’s goals and objectives guiding the implementation of TTA to support NCCCP grantees.	How would you describe the vision of the TTA program and how does this align with what your organization wants to achieve? Have your organization’s TTA goals and objectives changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
		Describe you and/or your organization’s role in the coordination/implementation of TTA for NCCCP grantees.	How do you/your organization’s help to plan, implement, and evaluate TTA? How would you describe your/your organization’s experience with participating in the TTA delivered?		X	X
		Describe your organization’s TTA activities that focused on local NCCCP state program implementation.	What topic areas were addressed? What strategies were promoted? What resources/tools were shared?	X			X
		Describe your organization’s TTA activities that supported implementation of policy, system, and/or environmental approaches?	What topic areas were addressed? What strategies were promoted? What resources/tools were shared?	X			X
		Describe your organization’s TTA activities that supported partnership sustainability?	What topic areas were addressed? What strategies were promoted? What resources/tools were shared?	X			X
		Describe your organization’s TTA activities aimed at increasing the reach of evidence-based/promising practices for implementation?	What topic areas were addressed? What strategies were promoted? What resources/tools were shared?	X			X
		Describe your organization’s efforts to promote NCCCP state programs’ success stories.	What communication strategies has your organization supported?	X			X
		Describe your organization's partnership with [DP13-1315 grantee organization name] with respect to implementation of TTA for NCCCP grantees.	How does your organization interact with [insert DP13-1315 grantee organization name]? How does your organization communicate with [insert DP13-1315 grantee organization name]? How often does your organization communicate with [insert DP13-1315 grantee organization name]? How long has your organization worked [insert DP13-1315 grantee organization name]? What components of TTTA does your organization support?			X
EQ 1D. What factors affect grantees' implementation of DP13-1315 FOA components?		What factors have affected your organization’s ability to implement the DP13-1315 FOA components? Please note and describe any factors that have changed since the beginning of the FOA. [follow-up only]	Are there any contextual factors that have affected your organization’s ability to implement FOA components? If so, which factors and components? Costs/funding Staffing/personnel Amount of time Program maturity/infrastructure Staff capacity Access to those with subject matter expertise Partnerships Are there any factors within your organization that have affected your ability to implement FOA components? If so, which factors and components? History Maturity Mission Leadership Are there any aspects of the cooperative agreement that have affected your organization’s ability to implement FOA components? If so, which factors and components? CDC TA received Tools/resources made available by CDC	X			X
		What resources, if any, has your organization provided to [insert Organization name] to support their provision of TTA to NCCCP grantees?	Has your organization provided additional funding? If so, please describe. Has your organization provided nonmonetary resources (such as volunteers, time, expertise, in-kind media donations)? If so, please describe.		X	X

Evaluation Question	DP13-1314	DP13-1315	Probes	Baseline			Follow Up
				PD/PM1	Evaluator	Partner	PD/PM
Evaluation Question 2: To what extent are DP13-1314 and DP13-1315 grantees implementing the components of the TTA framework?
EQ 2A. What components of the TTA framework are DP13-1314 grantees implementing?	Describe your organization’s activities aimed at planning TTA for TTA recipients.		How does your organization determine TTA needs among TTA recipients? Describe any specific strategies/methods used (e.g., needs assessment). What types of TTA planning activities has your organization implemented? How many TTA planning activities has your organization implemented? Have your organization’s TTA activities changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
	Describe your organization’s efforts to build and maintain partnerships among network members.		What strategies does your organization use to facilitate partnership building/engagement (e.g., communication)? What specific activities has your organization implemented to facilitate partnership building/engagement (e.g., meetings, calls)?	X			X
	Describe any trainings your organization has offered to increase capacity among TTA recipients.		What types of trainings has your organization offered? How many trainings has your program offered? How often have they occurred? What channels were used to deliver these trainings (e.g., webinars, in-person) What topics were addressed in these trainings? What evidence-based interventions and/or promising practices were promoted during trainings? Please provide specific examples. What resources were provided to training attendees (e.g., information, tools)	X			X
	Describe any technical assistance your organization has offered to increase capacity among TTA recipients.		What types of technical assistance has your organization offered? How often is technical assistance offered? What topics are addressed? What evidence-based interventions and/or promising practices were promoted? Please provide specific examples. What resources were provided (e.g., information, tools)?	X			X
	Describe your organization’s efforts to evaluate TTA provided to TTA recipients		Has your organization planned/implemented process evaluation activities to assess TTA? If so, please describe. Has your organization planned/implemented outcome evaluation activities to assess TTA? If so, please describe. Describe key findings from your organization’s TTA evaluation activities.	X			X
EQ 2B. What factors affect DP13-1314 grantees’ implementation of TTA framework components?	What factors have affected your organization’s ability to implement your TTA framework components? Please note and describe any factors that have changed since the beginning of the FOA. [follow-up only]		Are there any contextual factors that have affected your organization’s ability to implement FOA components? If so, which factors and components? Characteristics of your network? Characteristics of the NCCCP programs? Characteristics of the organizations of participating coalition members and partners Demographic or behavioral characteristics of the specific populations? Characteristics of the population-specific evidence-based interventions? Characteristics of your organization and the strategies you are using?	X			X
EQ 2C. What components of the TTA framework are DP13-1315 grantees implementing?		Describe your organization’s activities aimed at planning TTA for TTA recipients.	How does your organization determine TTA needs among TTA recipients? Describe any specific strategies/methods used (e.g., needs assessment). What types of TTA planning activities has your organization implemented? How many TTA planning activities has your organization implemented? Have your organization’s TTA activities changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
		Describe your organization’s efforts to build and maintain partnerships among TTA recipients.	What strategies does your organization use to facilitate partnership building/engagement (e.g., communication)? What specific activities has your organization implemented to facilitate partnership building/engagement (e.g., meetings, calls)?	X			X
		Describe any trainings your organization has offered to increase capacity among TTA recipients?	What types of trainings has your organization offered? How many trainings has your program offered? How often have they occurred? What channels were used to deliver these trainings (e.g., webinars, in-person) What topics were addressed in these trainings? What evidence-based interventions and/or promising practices were promoted during trainings? Please provide specific examples. What resources were provided to training attendees (e.g., information, tools)?	X			X
		Describe any technical assistance your organization has offered to increase capacity among TTA recipients.	What types of technical assistance has your organization offered? How often is technical assistance offered? What topics are addressed? What evidence-based interventions and/or promising practices were promoted? Please provide specific examples. What resources were provided (e.g., information, tools)?	X			X
		Describe your organization’s efforts to evaluate TTA provided to TTA recipients.	Has your organization planned/implemented process evaluation activities to assess TTA? If so, please describe. Has your organization planned/implemented outcome evaluation activities to assess TTA? If so, please describe. Describe key findings from your organization’s TTA evaluation activities.	X			X
EQ 2D. What factors affect 1315 grantees’ implementation of TTA framework components?		What factors have affected your organization’s ability to implement your TTA framework components? Please note and describe any factors that have changed since the beginning of the FOA. [follow-up only]	Are there any contextual factors that have affected your organization’s ability to implement FOA components? If so, which factors and components? Characteristics of the NCCCP programs? Characteristics of the organizations of participating state coalition members? Characteristics of affiliated partner organizations? Demographic or behavioral characteristics of the specific populations? Characteristics of the population-specific evidence-based interventions? Characteristics of your organization and the strategies you are using?	X			X

Evaluation Question	DP13-1314	DP13-1315	Probes	Baseline			Follow Up
				PD/PM1	Evaluator	Partner	PD/PM
Evaluation Questions 3: To what extent did DP13-1314 and DP13-1315 grantees achieve planned short-term outcomes?
EQ 3A.To what extent did DP13-1314 grantees achieve planned short-term outcomes? `	Describe how your organization measures the implementation of the network supported under the DP13-1314 FOA?		What data do you collect? Who is responsible for measuring/monitoring implementation? Are other staff members involved in data collection? How so? Are there plans to expand or change how your organization monitors implementation of the network? If so, please explain? Have your organization’s methods for measuring/monitoring implementation changed since the beginning of the FOA? If so, please describe. [follow-up only]	X	X		X
	Describe how your organization measures the extent to which your network implemented under DP13-1314 has achieved short-term outcomes?		What data do you collect? Who is responsible for measuring/monitoring implementation? Are other staff members involved in data collection? How so? Are there plans to expand or change how your organization monitors implementation of the network? If so, please explain? Have your organization’s methods for measuring short-term outcomes changed since the beginning of the FOA? If so, please describe. [follow-up only]	X	X		X
	To what extent have TTA recipients adopted tobacco use prevention and/or cancer prevention interventions as a priority?		To your knowledge, have NCCCP state programs adopted tobacco use prevention and/or cancer prevention interventions as a priority? Please provide any evidence. To your knowledge, have NCCCP state coalition members have adopted tobacco use prevention and/or cancer prevention interventions as a priority? Please provide any examples. To your knowledge, have other organizations adopted tobacco use prevention and/or cancer prevention interventions as a priority? Please provide any examples.	X			X
	To what extent have TTA recipients strengthened their support for tobacco use prevention and/or cancer prevention interventions?		How have NCCCP state programs strengthened their support? How have NCCCP state coalition members strengthened their support? How have other organizations strengthened their support?	X			X
	To what extent do TTA recipients report using newly adopted evidenced-based population-specific practice and/or service strategies for tobacco use prevention and/or cancer prevention?		Have NCCCP state programs reported adopting new evidence-based population-specific practices? Service strategies? Have NCCCP state coalition members reported adopting new evidence-based population-specific practices? Service strategies? Have other organizations reported adopting new evidence-based population-specific practices? Service strategies?	X			X
	To what extent has your organization disseminated culturally appropriate population specific strategies for tobacco use prevention and/or cancer prevention to network participants?		Have you disseminated culturally appropriate strategies to NCCCP state programs? Please describe. Have you disseminated culturally appropriate strategies to NCCCP state coalitions? Please describe. Have you disseminated culturally appropriate strategies to other organizations? Please describe.	X			X
	From your perspective, to what extent have culturally appropriate, population-specific strategies “spread” within network member organizations?		To what extent have culturally appropriate strategies been adopted throughout NCCCP state programs? Please provide any evidence. To what extent have culturally appropriate strategies been adopted by NCCCP state coalitions? Please provide any evidence. To what extent have culturally appropriate strategies been adopted by other organizations? Please provide any evidence.	X			X
EQ 3B.To what extent did DP13- 1315 grantees achieve planned short-term outcomes?		Describe how your organization measures the implementation of the TTA model supported under the DP13-1315 FOA?	What data do you collect? Who is responsible for measuring/monitoring implementation? Are other staff members involved in data collection? How so? Are there plans to expand or change how your organization monitors implementation of TTA? If so, please explain? Have your organization’s methods for measuring/monitoring implementation changed since the beginning of the FOA? If so, please describe. [follow-up only]	X	X		X
		Describe how your organization measures the extent to which the TTA your program has implemented under DP13-1315 has achieved short-term outcomes?	What data do you collect? Who is responsible for measuring/monitoring implementation? Are other staff members involved in data collection? How so? Are there plans to expand or change how your organization monitors implementation of TTA? If so, please explain? Have your organization’s methods for measuring short-term outcomes changed since the beginning of the FOA? If so, please describe. [follow-up only]	X	X		X
		Has your organization established a system to assure priority issues are addressed among TTA recipients? If so, please describe.	What infrastructure helps to support this system? How does the system operate? Who are the key staff within this organization that support this system? What are their roles?	X			X
		To what extent has your organization been successful in developing partnerships to facilitate the implementation and support of TTA activities?	How do partners help to implement specific elements of your program related to TTA? Describe the types of organizations that comprise you work in partnership with to implement TTA.	X			X
		To what extent has your organization worked directly with NCCCP state programs to improve local implementation?	Has your organization conducted any needs assessments with NCCCP state programs? If so, please describe. Has your organization disseminated promising practices among NCCCP state programs? If so, please describe. Has your organization provided NCCCP state programs with new resources/tools for local implementation? If so, please describe.	X			X
		From your perspective, to what extent have NCCCP state programs increased capacity for implementing NCCCP activities?	Have NCCCP state programs improved development and/or implementation of policies? If so, please provide examples. Have NCCCP state programs improved development and/or implementation of program systems? If so, please provide examples. Have NCCCP state programs improved implementation of environmental change strategies? If so, please provide examples. In what other ways have NCCCP state programs increased capacity? Please provide any evidence.	X			X

Evaluation Question	DP13-1314	DP13-1315	Probes	Baseline			Follow Up
				PD/PM1	Evaluator	Partner	PD/PM
Evaluation Questions 4: To what extent did DP13-1314 and DP13-1315 grantees TTA activities contribute to NCCCP implementation and achievement in NCCCP priorities and goals?
EQ 4A. How do key stakeholders from DP13-1314 perceive the effectiveness of TTA in contributing to NCCCP implementation and achievement in NCCCP goals?	From your perspective, do stakeholders perceive your organization’s TTA as effective in contributing to NCCCP implementation and achievement of goals? Please explain.		Do NCCCP state program staff see your TTA as effective? How do you know this? Please provide any evidence. Do NCCCP state coalition members see your TTA as effective? How do you know this? Please provide any evidence. Do other organizations see your TTA as effective? How do you know this? Please provide any evidence What aspects of your TTA do you think stakeholders see as most effective? What aspects of your TTA do you think stakeholders see as least effective? Has the perceived effectiveness of your organization’s TTA efforts changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
	From your perspective how effective do you perceive [insert DP13-1314 grantee organization name]’s TTA in contributing to NCCCP implementation and achievement of goals? Please explain.		Do NCCCP state program staff view [insert DP13-1314 grantee organization name]’s TTA as effective? What evidence has been collected to support this? Do NCCCP state coalition members see [insert DP13-1314 grantee organization name]’s TTA as effective? What evidence has been collected to support this? What aspects of [insert DP13-1314 grantee organization name]’s TTA do you think stakeholders see as most effective? What aspects of [insert DP13-1314 grantee organization name]’s TTA do you think stakeholders see as least effective?		X	X
	What suggestions, if any, have stakeholders provided for improving the effectiveness of your organization’s TTA? Please provide specific examples.			X			X
	What suggestions, if any, do you have for improving the effectiveness of [insert DP13-1314 grantee organization}’s TTA? Please provide specific examples.				X	X
EQ 4B. How do key stakeholders from DP13-1315 perceive the effectiveness of TTA in contributing to NCCCP implementation and achievement in NCCCP goals?		From your perspective, do stakeholders perceive your organization’s TTA as effective in contributing to NCCCP implementation and achievement of goals? Please explain.	Do NCCCP state program staff see your TTA as effective? How do you know this? Please provide any evidence. Do NCCCP state coalition members see your TTA as effective? How do you know this? Please provide any evidence. Do other organizations see your TTA as effective? How do you know this? Please provide any evidence What aspects of your TTA do you think stakeholders see as most effective? What aspects of your TTA do you think stakeholders see as least effective? Has the perceived effectiveness of your organization’s TTA efforts changed since the beginning of the FOA? If so, please describe. [follow-up only]	X			X
		From your perspective how effective do you perceive [insert DP13-1315 grantee organization name]’s TTA in contributing to NCCCP implementation and achievement of goals? Please explain.	Do NCCCP state program staff view [insert DP13-1315 grantee organization name]’s TTA as effective? What evidence has been collected to support this? Do NCCCP state coalition members see [insert DP13-1315 grantee organization name]’s TTA as effective? What evidence has been collected to support this? What aspects of [insert DP13-1315 grantee organization name]’s TTA do you think stakeholders see as most effective? What aspects of [insert DP13-1315 grantee organization name]’s TTA do you think stakeholders see as least effective?		X	X
		What suggestions, if any, have stakeholders provided for improving the effectiveness of your organization’s TTA? Please provide specific examples.		X			X
		What suggestions, if any, do you have for improving the effectiveness of [insert DP13-1315 grantee organization}’s TTA? Please provide specific examples.			X	X
EQ 4C. In what ways, if any, has the TTA provided by each FOA influenced the goals, priorities and activities of NCCCP-funded programs?
EQ 4D. To what extent has the TTA influenced NCCCP programmatic outcomes?

Evaluation Question	DP13-1314	DP13-1315	Probes	Baseline			Follow Up
				PD/PM1	Evaluator	Partner	PD/PM
Evaluation Question 5: What are the essential elements of a TTA model that build the capacity of NCCCP programs?
5A. Which, if any, of the TTA approaches, strategies or activities implemented under DP13-1314 contributed the most to improved NCCCP programmatic capacity and/or outcomes?	From your perspective, how has the national network model increased NCCCP capacity?		Which strategy, if any, resulted in increased capacity? How? From your perspective, which strategies would network members deem most essential for increasing capacity? Please explain. Which activities, if any, resulted in increased capacity? How? From your perspective, which activities would network members deem most essential for increasing capacity? Please explain.	X			X
	Overall, which aspects of the TTA model do you see as most essential for improving NCCCP capacity?		Which strategies are most essential? Why? Which activities are most essential? Why?	X	X	X	X
	From your perspective, how has the national network model improved NCCCP programmatic outcomes?		Which strategies, if any, resulted in improved outcomes? How? From your perspective, which strategies would network members deem most essential for improving outcomes? Please explain. Which activities, if any, resulted in improved outcomes? How? From your perspective, which activities would network members deem most essential for improving outcomes? Please explain.	X	X	X	X
	Overall, which aspects of the TTA model do you see as most essential for improving NCCCP programmatic outcomes?		Which strategies are most essential? Why? Which activities are most essential? Why?	X	X	X	X
	Describe any lessons learned from implementing the TTA under the DP13-1314 FOA.		What recommendations do you have for improving the TTA model used?	X			X
	Describe any lessons learned from supporting the TTA offered by [insert DP13-1314 grantee organization] under the DP13-1314 FOA.		What recommendations do you have for improving the TTA model used?		X	X
5B. Which, if any, of the TTA approaches, strategies or activities implemented under DP13-1315 contributed the most to improved CCC programmatic capacity and/or outcomes?		From your perspective, how has the TTA model you have used improved NCCCP programmatic capacity?	Which strategy, if any, resulted in increased capacity? How? From your perspective, which strategies would TTA recipients deem most essential for increasing capacity? Please explain. Which activities, if any, resulted in increased capacity? How? From your perspective, which activities would TTA recipients deem most essential for increasing capacity? Please explain.	X			X
		Overall, which aspects of the TTA model do you see as most essential for improving NCCCP capacity?	Which strategies are most essential? Why? Which activities are most essential? Why?	X	X	X	X
		From your perspective, how has the TTA model improved programmatic outcomes?	Which strategies, if any, resulted in improved outcomes? How? From your perspective, which strategies would TTA recipients deem most essential for improving outcomes? Please explain. Which activities, if any, resulted in improved outcomes? How? From your perspective, which activities would TTA recipients deem most essential for improving outcomes? Please explain.	X	X	X	X
		Describe any lessons learned from implementing TTA under the DP13-1315 FOA.	What recommendations do you have for improving the TTA model?	X			X
		Describe any lessons learned from supporting the TTA offered by [insert DP13-1315 grantee organization] under the DP13-1315 FOA.	What recommendations do you have for improving the TTA model used?		X	X
5C. What contextual factors, influence the effectiveness of each TTA model?	Describe any contextual factors that have impacted the effectiveness of the national network TTA model under DP13-1314?	Describe any contextual factors that have impacted the effectiveness of the TTA model under DP13-1315?	Have any external factors increased or decreased the effectiveness of the TTA model used? Characteristics of the FOA Characteristics of the population-specific networks Characteristics of the NCCCP state programs Characteristics of the organizations of participating coalition members and partners Demographic or behavioral characteristics of the specific populations Characteristics of the population-specific evidence-based interventions Characteristics of the systems and environmental strategies	X			X

1 Program Director/Program Manager

2 Boxes shaded ____denotes questions not asked of entire segment

Page 5 of 5